Amidaron

To prevent recurrences of:
- ventricular tachycardia, which is life-threatening; treatment should be initiated in a hospital setting with constant monitoring of the patient’s condition;
- symptomatic ventricular tachycardia (documented), which leads to disability;
- supraventricular tachycardia (documented), which requires treatment, and in cases where other medicinal products do not have a therapeutic effect or are contraindicated;
- ventricular fibrillation.
For the treatment of supraventricular tachycardia: slowing or reducing atrial fibrillation or flutter.
Coronary heart disease and/or left ventricular dysfunction (see section “Pharmacodynamics”).